SCHEMBL5149136

SCHEMBL5149136

CC1NC(=O)N(CCNc2ncc(Br)c(-c3cc4ccccc4s3)n2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MERTK Q12866 1/20 0.35
PIK3CA P42336 2/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
PRKDC P78527 1/20 0.33
PIK3R1 P27986 1/20 0.33
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33
CNR2 P34972 1/20 0.31
PGK1 P00558 1/20 0.30
ADORA2A P29274 1/20 0.30
ADORA1 P30542 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147380 0.82 ALDH1A1 (0.40) MERTKPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL2975085 0.82 MERTK (0.35) MERTKPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL5148423 0.80 FPR2 (0.34) MERTKPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL2975235 0.79 MERTK (0.34) MERTKPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL5149156 0.79 MERTK (0.35) MERTKPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL2984215 0.78 JAK2 (0.33) MERTKPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL2985538 0.78 SCN9A (0.42) MERTKADORA2AADORA1
SCHEMBL5183786 0.78 USP2 (0.33) MERTKPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL2982366 0.78 MERTK (0.34) MERTKPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL2971865 0.77 CCNC (0.33) MERTKPIK3CAPIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831207-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2007-09-12 EP disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed